Atlas Trials

Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer

Clinical trial NCT01237327 · COMPLETED

Trial details

NCT number
NCT01237327
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2001-11-01
Primary completion
2007-12-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.